4 min read

AI-powered pneumonia detection revolutionises healthcare in India

AI-powered pneumonia detection revolutionises healthcare in India unknown

By Narayana Darapaneni

Pneumonia remains a major public health challenge in India. It accounts for a remarkable number of hospitalisations and deaths, particularly in rural regions and areas deprived of healthcare resources. Diagnosis often relies on clinical assessment and radiological findings from chest X-rays, which can be time-consuming and prone to interpretation errors. As early detection and accurate diagnosis are crucial to treating this infectious disease effectively, the need for a faster and more accurate diagnostic approach has ignited the integration of artificial intelligence (AI) technology to combat the infection, revolutionising the country’s healthcare.

India’s Digital Healthcare Landscape

This revolution goes back to several governmental initiatives over the past few years. For instance, the draft National Strategy for Artificial Intelligence highlights that increased advances in technology insights from innovators provide an opportunity to solve a few long-existing challenges in providing appropriate healthcare to India’s population on a large scale. The government is also trying to create a national digital health infrastructure, as mentioned in its policy documents for the National Health Stack (2018). Key features of this digital infrastructure include Health Lockers (an electronic national health registry and cloud-based data storage system that would serve as a single source of health data for the nation), a federated personal health records (PHR) framework that allows data to be available both to citizens and for medical research, a coverage and claims platform that would support large health protection schemes, a national health analytics platform, and a unique digital health ID for each citizen. The prioritisation of AI for healthcare has created an impetus for greater collaboration between government, technology companies, and traditional healthcare providers. For example, NITI Aayog, the government’s official policy think-tank, is working with Microsoft and the medical technology start-up Forus Health to develop a pilot for the early detection of diseases. The Maharashtra state government has also signed a memorandum of understanding with NITI Aayog and the Wadhwani AI group to launch the International Centre for Transformational Artificial Intelligence (ICTAI), focusing on rural healthcare. The government also launched Ayushman Bharat, which was devised to provide health insurance to low-income families. These build on the earlier National Health Policy (2017), which envisaged enhancing public health outcomes through big data analytics. These policies call for a state-backed or state-enabled digital infrastructure for data exchange, then accessible to the private sector for further innovation based on open application programming interfaces (APIs) and national data portability. All of this indicates the government’s foresight about integrating AI and other technologies in healthcare to be future ready. With a robust ecosystem under construction, the fight against pneumonia is bound to get easier, especially in conjunction with AI systems that can connect with various digital platforms.

AI-Powered Pneumonia Detection

AI-powered systems have shown tremendous potential in pneumonia detection, significantly enhancing the identification of causes, improving preventive measures like vaccination, and bettering the diagnostic process and response assessment to the treatment. Machine learning algorithms trained on large datasets of chest X-rays and CT scans can quickly analyse images and identify patterns associated with pneumonia. These algorithms can recognise subtle abnormalities indicative of the disease that might be overlooked by human observers. The speed and accuracy of AI-based diagnosis streamline the process, enabling prompt initiation of treatment, thus reducing the risk of complications. In situations like a pandemic, AI can be deployed for large-scale screening efforts: Analysing chest X-rays from a large number of people can help identify potential cases of pneumonia and aid in early containment measures. And by integrating the public survey datasets and the health sector data, more comprehensive care can be provided.

Accessibility in Remote Areas

One of the most significant advantages of AI-powered pneumonia detection is its capability to bridge the healthcare accessibility gap between urban and underserved areas. In India, where access to specialised medical facilities is minimal in rural regions, AI technology offers a cost-effective solution with the availability of portable X-ray machines and AI-driven diagnostic tools. Healthcare workers in remote areas can take chest X-rays and transmit the images to centralised AI systems for rapid evaluation. This decentralisation of pneumonia diagnosis ensures that even underserved communities can receive timely and accurate healthcare interventions.

Efficiency and Cost-Effectiveness

AI-powered pneumonia detection not only improves diagnostic accuracy but also optimises resource utilisation in the healthcare sector. By minimising the time taken for diagnosis, hospitals and clinics can manage patient flow more efficiently, leading to better utilisation of staff and facilities. Also, AI algorithms can prioritise severe cases, further helping healthcare providers allocate resources appropriately and reduce the stress on overcrowded healthcare facilities.

Constant Improvement and Research

AI’s adaptability and learning capabilities create possibilities for continuous improvement in pneumonia detection and treatment strategies. As AI systems process more data and handle a broader range of pneumonia cases, their diagnostic accuracy and sensitivity improve further. Moreover, the vast amount of anonymised data collected through AI-powered systems can be invaluable for researchers and epidemiologists in studying disease trends, tracking outbreaks, and devising targeted public health interventions. AI can aid in drug discovery processes, identifying potential new treatments for pneumonia and optimising existing treatments based on patient outcomes and medical literature.

Challenges and Ethical Considerations

While the integration of AI to detect pneumonia brings forth numerous benefits, it also raises certain challenges and ethical considerations. Data privacy and security are of paramount importance, and healthcare institutions must ensure that patient information is handled with the utmost care and complies with relevant regulations. Additionally, there is a need to address potential biases in AI algorithms, which may arise due to imbalanced datasets or improper training methodologies.

The deployment of AI is still at a very early stage, particularly in the form of clinical interventions. A number of the identified use cases are still at a development and testing level, while most of the current use cases take the form of decision support systems, followed by process optimisation and virtual assistants. In time, by harnessing the full power of AI, healthcare providers can save lives, optimise resources, and improve overall healthcare outcomes. However, it is essential to maintain a careful balance between the benefits of AI technology and the ethical considerations associated with data privacy and algorithmic bias. Through responsible implementation and continued research, AI-driven healthcare solutions will continue to play a transformative role in battling pneumonia and other critical health challenges in India.

The author is professor AI and ML, Great Learning

Follow us on TwitterFacebookLinkedIn